Effects of Unsuppressed Endogenous Insulin on Pharmacokinetics and/or Pharmacodynamics of Study Insulin in the Healthy: A Retrospective Study

C‐peptide, a marker of endogenous insulin, should be consistently inhibited during euglycemic clamping, while an elevated postdosing C‐peptide (CP(postdosing)) is not an occasional phenomenon. This was a retrospective study that included 33 men who underwent a manual euglycemic clamp with a subcutan...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Hui, Yu, Hongling, Sun, Lisi, Qiao, Jingtao, Li, Jiaqi, Tan, Huiwen, Yu, Yerong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9546084/
https://www.ncbi.nlm.nih.gov/pubmed/35384402
http://dx.doi.org/10.1002/cpdd.1093

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9546084/
https://www.ncbi.nlm.nih.gov/pubmed/35384402
http://dx.doi.org/10.1002/cpdd.1093

Ejemplares similares